The conolidine Diaries
These benefits, together with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 support the idea of concentrating on ACKR3 as a novel technique to modulate the opioid system, which could open new therapeutic avenues for opioid-associated Issues.These benefits advise that conolidine